Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

INFINITI LABS, INC

NPI: 1356645295 · TAMPA, FL 33634 · Clinical Medical Laboratory · NPI assigned 01/07/2011

$2.53M
Total Medicaid Paid
562,747
Total Claims
401,317
Beneficiaries
44
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialNELSON, GREG (PRESIDENT)
NPI Enumeration Date01/07/2011

Related Entities

Other providers sharing the same authorized official: NELSON, GREG

ProviderCityStateTotal Paid
APEX LABS, INC TAMPA FL $1.58M
NELSON-NAM A MEDICAL CORPORATION VAN NUYS CA $86K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 161,336 $883K
2019 186,370 $565K
2020 95,425 $381K
2021 49,574 $271K
2022 36,926 $247K
2023 26,645 $144K
2024 6,471 $40K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 28,181 20,030 $826K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 20,280 17,200 $662K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 20,341 15,313 $207K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 5,172 4,913 $183K
80325 12,885 9,970 $45K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,259 1,126 $38K
80365 34,497 14,615 $36K
80333 12,012 9,251 $30K
80351 1,929 1,237 $29K
80346 17,005 13,401 $28K
80356 17,852 14,222 $26K
80354 19,998 13,362 $24K
80368 21,503 9,447 $24K
80361 18,294 14,612 $24K
80336 12,976 9,391 $23K
80348 18,309 14,606 $21K
80359 17,847 14,218 $20K
80338 15,819 9,264 $19K
80349 16,581 13,067 $19K
80373 16,772 13,353 $19K
80372 16,696 13,285 $19K
80360 15,990 12,539 $19K
83992 17,169 13,583 $18K
80366 14,703 11,389 $17K
80370 14,497 11,200 $17K
80355 14,486 11,188 $17K
80364 9,712 7,239 $16K
80357 11,017 8,338 $16K
80353 17,871 14,234 $15K
80342 9,558 7,157 $14K
80358 17,243 13,722 $13K
80367 13,740 10,726 $12K
80324 7,619 4,302 $10K
84311 19,070 7,601 $7K
80362 8,407 4,341 $5K
80344 2,550 2,160 $3K
80321 1,433 1,242 $2K
80371 3,494 965 $2K
80339 2,574 1,862 $1K
80369 471 439 $1K
80323 2,579 1,362 $958.37
80363 3,187 2,787 $753.47
82570 9,142 7,034 $520.09
80343 27 24 $139.50